tiprankstipranks
MEI Pharma (MEIP)
NASDAQ:MEIP
US Market

MEI Pharma (MEIP) Income Statement

Compare
995 Followers

MEI Pharma Income Statement

Last quarter (Q2 2025), MEI Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, MEI Pharma's net income was $-2.68M. See MEI Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 65.30M$ 48.82M$ 40.70M$ 25.54M$ 28.91M
Gross Profit
$ 64.91M$ 47.00M$ 39.46M$ 24.13M$ 26.24M
Operating Expenses
$ 50.76M$ 85.58M$ 116.18M$ 93.81M$ 50.78M
Depreciation and Amortization
$ 383.00K$ 1.81M$ 1.24M$ 285.00K$ 109.00K
EBITDA
$ 26.38M$ -36.76M$ -75.16M$ -60.14M$ -25.59M
Operating Income
$ 14.54M$ -36.76M$ -75.48M$ -69.69M$ -24.54M
Other Income/Expenses
$ 3.24M$ 4.93M$ 21.03M$ 19.12M$ -21.48M
Pretax Income
$ 17.78M$ -31.84M$ -54.45M$ -50.57M$ -46.02M
Net Income
$ 17.78M$ -31.84M$ -54.45M$ -41.31M$ -47.17M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 2.67$ -4.78$ -8.75$ -7.40$ -10.40
Diluted EPS
$ 2.67$ -4.78$ -9.99$ -12.00$ -10.40
Weighted Average Shares Outstanding
6.66M 6.66M 6.22M 5.63M 4.55M
Weighted Average Shares Outstanding (Diluted)
6.66M 6.66M 6.26M 5.72M 4.55M
Currency in USD

MEI Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis